Skip to content
ETEN
Findshops
Politics

Germany’s Medical Cannabis Prescriptions: What Changed in 2024 and 2026?

Illustrative photograph of the Reichstag building in Berlin

Updated 6 November 2026. Germany changed statutory insurance approval arrangements for medical cannabis prescriptions on 17 October 2024. This did not automatically allow every doctor to prescribe free or insurance-funded cannabis to every patient. Reimbursement rules changed again in July 2026, so the 2024 position cannot be presented as current.

What changed on 17 October 2024?

Reichstag building in Berlin
Illustrative photograph from Germany. Photo: Niki Nagy / Pexels.

The Federal Joint Committee, G-BA, removed mandatory prior insurance approval for doctors with specified specialties and additional qualifications. The exception covered 16 specialties or specialisations and five additional qualifications.

Appropriately qualified general practitioners and some specialists in internal medicine, neurology, psychiatry or pain medicine could prescribe in suitable cases without mandatory prior approval. Other doctors remained subject to the normal approval procedure, and medical eligibility requirements continued to apply.

What changed in 2026?

Under changes effective on 30 July 2026, dried cannabis flowers were generally excluded from statutory insurance reimbursement. Standardised extracts and medicines containing substances such as dronabinol or nabilone may still be covered under specified conditions. Separate medical requirements govern prescribing and reimbursement.

A doctor’s ability to prescribe and an insurer’s duty to pay must therefore be distinguished. Easing prescriptions in 2024 did not create unconditional entitlement to insurance-funded flowers.

Can medical cannabis still be obtained from German pharmacies?

Yes. Prescription availability and statutory insurance reimbursement are separate matters. Eligible patients may receive pharmacy-dispensed cannabis, while coverage depends on product type, insurance status and reimbursement rules.

The Federal Health Ministry has also proposed stricter requirements for remote flower prescriptions and mail-order sales. A draft’s existence does not establish that every proposal has taken effect; proposals must be distinguished from current rules.

What does the reform’s development show?

The 2024 change reduced approval requirements for selected doctors. Stricter reimbursement in 2026 shows the system remains in flux. Patients need to check prescribing, pharmacy dispensing and coverage for the particular product together. A separate law governs adult personal use, explained in our German cannabis reform overview.

Sources

Share article
REKLAAMIPIND
Your ad here

Advertising space available.

Get in touch ↗

Lisa kommentaar

Your email address will not be published. Required fields are marked *